non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer#831724ClinicalTrials.gov
• Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.#162488ClinicalTrials.gov
• Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer#261513ClinicalTrials.gov
• Perioperative Rehabilitation in Operation for Lung Cancer#807794ClinicalTrials.gov
• Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy#346934ClinicalTrials.gov
• An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck#826916ClinicalTrials.gov
• A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)#623516ClinicalTrials.gov
• Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer#394753ClinicalTrials.gov
• Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer#426778ClinicalTrials.gov
• Phenotypic and histological distribution analysis identify mast cell heterogeneity in non-small cell lung cancer#161285HAL (France)
• Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)#121328ClinicalTrials.gov
• Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)#181773ClinicalTrials.gov
• Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer#256897ClinicalTrials.gov
• Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer#303650ClinicalTrials.gov
• Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer#346911ClinicalTrials.gov
• Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer#369822ClinicalTrials.gov
• Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer#463720ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)#481755ClinicalTrials.gov
• A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients#640440ClinicalTrials.gov
• Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC#842304ClinicalTrials.gov
• T-Cell PET Imaging With [18F]F-AraG in Lung Cancer#300241ClinicalTrials.gov
• Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer#832459ClinicalTrials.gov
• Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy#208432ClinicalTrials.gov
• A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations#841835ClinicalTrials.gov
• The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer#842372ClinicalTrials.gov
• Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer#121343ClinicalTrials.gov
• Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer#172411ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer#373657ClinicalTrials.gov
• Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study#127610ClinicalTrials.gov
• Metronomic Oral Vinorelbine in Patients With Metastatic Tumors#829949ClinicalTrials.gov
• CIETAI and Sequential Radiotherapy in Squamous Lung Cancer#249602ClinicalTrials.gov
• Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure#136302ClinicalTrials.gov
• Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial#136323ClinicalTrials.gov
• Energy for Lymphocytes#256899ClinicalTrials.gov
• NADIM II: Neo-Adjuvant Immunotherapy#283051ClinicalTrials.gov
• Lung Cancer Incidence Trends in South Africa from 2011 to 2022 and Investigation of Non- Small Cell Lung Cancer Biomarkers Using Rule-Based Natural Language Processing#447674WIReDSpace
• Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC#836486ClinicalTrials.gov
• BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)#828520ClinicalTrials.gov
• Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now#146443ClinicalTrials.gov
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer#287547ClinicalTrials.gov
• Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer#807791ClinicalTrials.gov
• Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases#154655ClinicalTrials.gov
• A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement#806772ClinicalTrials.gov
• A Phase I Study of CFT8919 in Patients With Advanced NSCLC#839858ClinicalTrials.gov
• Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)#829876ClinicalTrials.gov
• A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.#646483PubMed
• Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer#830215ClinicalTrials.gov
• Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer#174886ClinicalTrials.gov
• Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)#123472ClinicalTrials.gov
• Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)#829589ClinicalTrials.gov